|Pharmium Securities
About us
Pharmium Securities is an independent Equity Research & Corporate Finance boutique specialized on biotechnology.
Pharmium Securities was established with the aim of responding to the crucial need of a specialized boutique in biotechnology based on deep market and company analysis, strong knowledge and reliable information. The company has built an experienced team in both Equity research and corporate finance within the biotechnology sector. Our management has been involved in IPO process and private placement.
We are unique in France as we offer investors research from biotech specialist able to navigate between commercial, clinical and regulatory setbacks. Pharmium Securities offers proprietary equity research to investors on US and European biotech companies. Pharmium Securities covers 12 listed biotech companies with a main focus on small and mid-size European (French and Scandinavian) stocks.
More than 50 stocks are under scrutiny.
- #1 Equity research independent boutique in terms of stocks covered and geographical approach in France
- 100% management-owned, no competing activities (like corporate brokerage)
More
-
Our research is available upon subscription.
Please contact us for more details.